Brind.

Fidelity Investments and Bristol Myers Squibb are utilizing the ModelOp platform to accelerate innovation, which is led by Jim Olsen as CTO.

1 report, 1 independent Updated Jul 24

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Fidelity Investments Bristol-Myers Squibb

Keep exploring

The entities involved

Fidelity Investments
US American multinational financial services corporation

Nothing else this week.
Bristol-Myers Squibb
American pharmaceutical company
- Bristol-Myers Squibb is developing innovative treatments and supporting Cyprus' national effort in haematology.Mon 13:45
- FDA gave tentative approval to Lupin for an alternative formulation of a Bristol-Myers Squibb drug, which Lupin plans to manufacture in Somerset.Mon 09:09

Coverage

Newest first; wire copies grouped

Jul 24GlobeNewswireModelOp Transforms Enterprise AI Governance with Launch of the First Agentic AI Chat Interface and Controls for Agentic AI ModelOp’s new Agentic AI Chat Interface and end-to-end lifecycle automation